Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients With Advanced NSCLC [Phase 1]

View source ↗

Summary

Phase 1 study reports safety, tolerability, and pharmacokinetics of multiple ascending doses of Simotinib Hydrochloride in patients with advanced non-small cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Simotinib Hydrochloride (simotinib hydrochloride)

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Non-small Cell Lung Cancer | Phase 1 | Status: UNKNOWN